NCT06935227

Brief Summary

Currently, the incidence of involutional and chronic eyelid disorders, such as ectropion, has been increasing, as human life expectancy has risen worldwide (more than 600 million people are aged ≥ 60 years). Ectropion is a common eyelid malposition that causes visual morbidity. It is characterized by eversion of the eyelid margin and has multiple etiologies. Steri-Strip tapes have been used in some ophthalmologic procedures, such as blepharoplasties, where they help prevent infections by acting as a barrier method, are resistant enough to reduce the risk of wound dehiscence, simplify postoperative care, and allow for proper eyelid fissure closure. Their use has been recommended in patients with facial paralysis to prevent keratitis or exposure ulcers. However, current evidence is limited, as their use has only been documented in case series and letters to the editor. Therefore, a randomized controlled clinical trial is proposed to evaluate the postoperative outcomes of Steri-Strip tape use in unilateral ectropion surgery compared to standard postoperative management.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 11, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

9 months

First QC Date

April 11, 2025

Last Update Submit

June 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Eyelid position

    This outcome will be assessed using the margin reflex distance 2 (MRD2), which will be measured in millimeters (mm) from the central corneal light reflex (Hirschberg reflex) to the center of the lower eyelid margin. If this measurement exceeds 5 mm, it suggests that the tapes did not provide adequate support.

    Measurements will be taken in the immediate postoperative period (within the first hour) and at 30 days following surgery.

Secondary Outcomes (3)

  • Surgical wound closure

    This will be assessed on postoperative day 8

  • Visual axis obstruction secondary to peripalpebral edema

    It will be assessed on postoperative day 8.

  • Ocular surface symptoms

    This outcome will be assessed on postoperative days 8 and 30.

Study Arms (2)

Use Steri-Strip in post-surgery + standard care

ACTIVE COMPARATOR

Within the first hour after unilateral ectropion surgery, Steri-Strip tapes (6 mm wide × 100 mm long, pack of 10 strips) will be applied to the operated eye. Six of these strips will be placed obliquely, hammock-style, 3 mm below the inferior orbital rim to direct the tension forces upward, using the lateral canthus of the operated eye as support. An additional strip will be placed horizontally, 2 mm above the orbital rim. The Steri-Strip tapes will be removed 8 days after surgery.

Other: Use Steri-Strip in post-surgery + standard care

Standard care

OTHER

Standard care for ectropion surgery refers to the usual postoperative management provided without the use of additional supportive devices such as Steri-Strip tapes. It typically includes the application of ophthalmic antibiotic ointment, cold compresses, and instructions for eyelid hygiene.

Other: Standard care

Interventions

Steri-strip will be maintained for 8 days postoperatively.

Use Steri-Strip in post-surgery + standard care

Postoperative care recommendations.

Standard care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years or older who are scheduled to undergo unilateral ectropion surgery.

You may not qualify if:

  • Underlying conditions associated with skin hyperlaxity, such as cutis laxa and Ehlers-Danlos syndrome.
  • Skin diseases that predispose to cicatricial ectropion, such as ichthyosis, scleroderma, and psoriasis.
  • Paralytic ectropion.
  • Current use of oral isotretinoin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oftalmosanitas

Bogotá, Colombia

RECRUITING

MeSH Terms

Conditions

Ectropion

Interventions

Postoperative PeriodStandard of Care

Condition Hierarchy (Ancestors)

Eyelid DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Perioperative PeriodSurgical Procedures, OperativePatient CareHealth ServicesHealth Care Facilities Workforce and ServicesQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Tatiana Gomez, MD

    Unisanitas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Johana Benavides, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

April 11, 2025

First Posted

April 20, 2025

Study Start

May 1, 2025

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

June 11, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations